Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miki Koshimizu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Pharmacology & Therapeutics|June 21, 2005
A novel paradigm for therapeutic basis of advanced heart failure--assessment by gene therapyTomie Kawada, Fujiko Masui, Hiroyuki Kumagai, et al.
Journal of Cardiovascular Pharmacology|April 25, 2006
Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarctionMasaya Takahashi, Kouichi Tanonaka, Hiroyuki Yoshida, et al.
European Journal of Pharmacology|September 28, 2005
Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligationMasaya Takahashi, Kouichi Tanonaka, Hiroyuki Yoshida, et al.
Cardiovascular Research|August 12, 2003
Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarctionHiroyuki Yoshida, Masaya Takahashi, Miki Koshimizu, et al.
Cardiovascular Research|January 11, 2005
Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heartMasaya Takahashi, Kouichi Tanonaka, Hiroyuki Yoshida, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pharmacology & Therapeutics|June 21, 2005
A novel paradigm for therapeutic basis of advanced heart failure--assessment by gene therapyTomie Kawada, Fujiko Masui, Hiroyuki Kumagai, et al.
Journal of Cardiovascular Pharmacology|April 25, 2006
Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarctionMasaya Takahashi, Kouichi Tanonaka, Hiroyuki Yoshida, et al.
European Journal of Pharmacology|September 28, 2005
Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligationMasaya Takahashi, Kouichi Tanonaka, Hiroyuki Yoshida, et al.
Cardiovascular Research|August 12, 2003
Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarctionHiroyuki Yoshida, Masaya Takahashi, Miki Koshimizu, et al.
Cardiovascular Research|January 11, 2005
Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heartMasaya Takahashi, Kouichi Tanonaka, Hiroyuki Yoshida, et al.
Pageof 1